Click on image to view larger version.

Figure 1 ORs for High On-Clopidogrel Platelet Reactivity According to CYP2C19*2 Genotype

Odds ratios (ORs) with 95% confidence intervals for residual platelet aggregation (RPA) >14% after stimulation of platelet-rich plasma with adenosine diphosphate 5 µmol/l comparing patients (Pts) carrying at least 1 CYP2C19 *2 allelic variant with wild-type homozygotes before percutaneous coronary intervention (PCI) and pre-discharge with and without adjustment for baseline variables (Table 1), with a difference between carriers of the CYP2C19*2 allele and wild-type homozygotes at a value of p 0.20. Odds ratios and p values were derived from logistic regression models.